Skip to main content
. 2020 Mar 30;18:145. doi: 10.1186/s12967-020-02308-w

Table 2.

Cox proportional-danger model analysis of bladder cancer patients

Factors Univariate analysis Multivariable analysis
HR (95% CI) P HR (95% CI) P
Gender < 0.001
 Male Reference Reference
 Female 1.10 (1.10–1.10) < 0.001 0.99 (0.96–1.01) 0.336
Age (years) < 0.001
 00–50 Reference Reference
 51–60 1.30 (1.20–1.50) < 0.001 1.34 (1.23–1.46) < 0.001
 61–70 1.60 (1.50–1.80) < 0.001 1.70 (1.57–1.85) < 0.001
 71–80 2.60 (2.40–2.80) < 0.001 2.80 (2.59–3.03) < 0.001
 81+ 5.20 (4.80–5.60) < 0.001 5.84 (5.39–6.31) < 0.001
Racial < 0.001
 API Reference Reference
 AIAN 1.37 (1.14–1.65) < 0.001 1.31 (1.09–1.57) < 0.001
 Black 1.51 (1.41–1.62) < 0.001 1.56 (1.46–1.67) < 0.001
 White 1.11 (1.05–1.17) < 0.001 1.18 (1.12–1.25) < 0.001
Surgery < 0.001
 No Reference Reference
 Yes 0.62 (0.59–0.64) < 0.001 0.72 (0.69–0.75) < 0.001
Summary stage < 0.001
 In situ Reference Reference
 Localized 2.5 (2.4–2.6) < 0.001 1.27 (1.12–1.44) < 0.001
 Regional 5.1 (4.9–5.3) < 0.001 1.36 (1.14–1.62) < 0.001
 Distant 15.9 (15.3–16.5) < 0.001 3.03 (2.52–3.63) < 0.001
AJCC stage < 0.001
 Stage 0a Reference Reference
 Stage 0is 1.4 (1.3–1.5) < 0.001 1.18 (1.10–1.26) < 0.001
 Stage I 1.9 (1.8–1.9) < 0.001 1.39 (1.22–1.58) < 0.001
 Stage II 4.4 (4.3–4.6) < 0.001 3.22 (2.83–3.66) < 0.001
 Stage III 4.7 (4.5–4.9) < 0.001 3.38 (2.82–4.05) < 0.001
 Stage IV 10.9 (10.5–11.2) < 0.001 5.48 (4.57–6.57) < 0.001
Histologic type < 0.001
 Transitional Reference Reference
 Adenocarcinomas 2.25 (2.05–2.46) < 0.001 1.04 (0.95–1.15) 0.371
 Epithelial 3.07 (2.89–3.27) < 0.001 1.37 (1.29–1.46) <  0.001
 Squamous 3.32 (3.12–3.54) <  0.001 1.77 (1.66–1.89) <  0.001
 Unspecified 2.82 (2.54–3.13) <  0.001 1.20 (1.08–1.34) <  0.001

HR hazard ratio, CI confidence interval, AIAN American Indian/Alaska Native, API Asian or Pacific Islander